BridgeMD
New treatment option for Phosphate Diabetes
Official title Phosphorus-31 Spectroscopy in Phosphate Diabetes
ClinicalTrials.gov ID: NCT06921720
What this study is testing
- What it's testing
- Phosphate diabetes is defined by urinary phosphate wasting due to impaired tubular reabsorption. It can be classified based on either a genetic or acquired origin.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 10 and older. Healthy volunteers may be eligible.
You may be able to join if
- for Patients:
- Patient ≥ 10 years old with phosphate diabetes, i.e., genetically confirmed XLH or phosphate diabetes of another origin characterized by...
- Patient has given consent to participate in the study.
- Signed consent (by both legal representatives for minor patients).
- Patient regularly followed up within the pediatric nephrology services at the Femme Mère Enfant hospital and the nephrology-functional exploration...
You likely can't join if
- Pregnant, parturient, or breastfeeding women
- Individuals deprived of liberty by a judicial or administrative decision
- Individuals receiving psychiatric care
- Individuals admitted to a healthcare or social institution for purposes other than research
- Adults under legal protection (guardianship, curators)
- Individuals not affiliated with a social security system or benefiting from a similar scheme
See the full eligibility criteria
- for Patients:
- Patient ≥ 10 years old with phosphate diabetes, i.e., genetically confirmed XLH or phosphate diabetes of another origin characterized by hypophosphatemia with a decreased Tm/GFR.
- Patient has given consent to participate in the study.
- Signed consent (by both legal representatives for minor patients).
- Patient regularly followed up within the pediatric nephrology services at the Femme Mère Enfant hospital and the nephrology-functional exploration services at the Edouard Herriot hospital. for Pediatric Controls:
- Patient aged 10 to 17 years, without chronic kidney disease, without hypophosphatemia, without muscular abnormalities, and without growth disorders.
- Patient has given consent to participate in the study.
- Signed consent (by both legal representatives for minor patients).
- Patient regularly followed up within the pediatric nephrology services at the Femme Mère Enfant hospital. for Adult Controls:
- Patient without chronic kidney disease, without hypophosphatemia, without muscular abnormalities, and without malnutrition.
- Patient has given consent to participate in the study.
- Signed consent.
- Patient regularly followed up within the renal functional exploration services at the Edouard Herriot hospital.
- Pregnant, parturient, or breastfeeding women
- Individuals deprived of liberty by a judicial or administrative decision
- Individuals receiving psychiatric care
- Individuals admitted to a healthcare or social institution for purposes other than research
- Adults under legal protection (guardianship, curators)
- Individuals not affiliated with a social security system or benefiting from a similar scheme
- people participating in another treatment study with an exclusion period still in effect at pre-inclusion
- General contraindications for MRI: wearing a pacemaker/ICD (implantable cardiac device) or mechanical heart valves not MRI-compatible, presence of non-MRI-compatible equipment, presence of metallic objects.
The study team makes the final eligibility decision.
Where it's taking place
- Bron, France
- Lyon, France
Compensation & support
Compensation mentioned.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 10 years and older. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Bron, France; Lyon, France. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.